We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
David Brodland

David G. Brodland MD

Zitelli & Brodland PC, Skin Cancer Center, Pittsburgh, Pennsylvania

Recent Contributions to PracticeUpdate:

  1. Mohs Micrographic Surgery With MART-1 Immunostaining Has Durable Low Local Recurrence Rates for In Situ and Invasive Melanomas
  2. Factors Affecting Sentinel Node Metastasis in Thin Cutaneous Melanomas
  3. Postoperative Pain Control in Mohs Micrographic Surgery
  4. Optimal Timing of Postoperative Pharmacologic Pain Control in Mohs Micrographic Surgery
  5. Early Melanoma Nodal Positivity and Biopsy Rates Before and After Implementation of AJCC 7
  6. Opioid Prescribing Patterns After Micrographic Surgery
  7. Opioid Prescribing for Acute Postoperative Pain After Cutaneous Surgery
  8. Mohs Micrographic Surgery With MART-1 Immunostaining for Atypical Intraepidermal Melanocytic Proliferation
  9. Outcomes, Risks, and Costs of Local vs General Anesthesia
  10. Opioid and Nonopioid Analgesics Have Similar Efficacy for Acute Extremity Pain in the Emergency Department

Most Read This Week

Recently Updated